SomaLogic Adam Taich, EVP Life Sciences, promoted to interim CEO with a focus on operational execution Board transition adds industry veterans: Jason Ryan as Chairman; Tycho Peterson, Kathy Hibbs, and Tom Carey as Independent Directors Fourth quarter 2022 revenue of $18.8 million; full year 2022 revenue of $97.7 million Full year 2023 revenue guidance of $80-84 million, reflecting 12-17{9f99fe44fce1aa3c813d0a0ce4da2fbea8a5a58e9d85c4a2927dd8140cb676b5} growth over 2022, excluding licensing revenue from New England Biolabs Substantial balance sheet provides flexibility with cash and investments of $539.6 million at year-end 2022 Working with advisors to pursue offensive strategic options including transformational opportunities Management to host a conference call today at 4:30 pm ET. BOULDER, Colo., March 28,…